Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Depreciation & Amortization (CF) (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Depreciation & Amortization (CF) data on record, last reported at $5000.0 in Q4 2019.

  • For Q4 2019, Depreciation & Amortization (CF) changed 0.0% year-over-year to $5000.0; the TTM value through Dec 2019 reached $21000.0, up 40.0%, while the annual FY2024 figure was $39000.0, 30.0% up from the prior year.
  • Depreciation & Amortization (CF) reached $5000.0 in Q4 2019 per DMAC's latest filing, roughly flat from $5000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $6000.0 in Q1 2019 and bottomed at $2000.0 in Q2 2018.